Beam Therapeutics (BEAM) Other Non Operating Income (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Other Non Operating Income data on file, last reported at $2.5 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $2.5 million, down 21.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $940000.0 (down 88.77% YoY), and the FY2025 annual result was $700000.0, down 69.19% from the prior year.
• Other Non Operating Income climbed to $2.5 million in Q1 2026 per BEAM's latest filing, from $50000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $13.6 million in Q1 2022 and troughed at -$4.9 million in Q3 2022.
• A 5-year average of $2.2 million and a median of $1.1 million in 2025 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income soared 815.79% in 2022, then tumbled 1278.5% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $3.0 million in 2022, then plunged by 163.33% to -$1.9 million in 2023, then surged by 93.26% to -$128000.0 in 2024, then surged by 139.06% to $50000.0 in 2025, then soared by 4900.0% to $2.5 million in 2026.
• Business Quant data shows BEAM's Other Non Operating Income at $2.5 million in Q1 2026, $50000.0 in Q4 2025, and -$2.8 million in Q3 2025.